Friday, August 22nd, 2025

AEM Holdings Ltd 2025-2027 Outlook: Earnings Recovery, Risks, and Target Price Analysis

Broker: CGS International
Date of Report: August 20, 2025

AEM Holdings Ltd: Awaiting the Next Wave — Financial Outlook, Risks, and Opportunities in 2025-2027

Introduction: CGS International Resumes Coverage on AEM Holdings Ltd

AEM Holdings Ltd, a leading Singapore-based semiconductor test solutions provider, finds itself at a crossroads in 2025. While the first half of the year brought a rebound in revenue and profit, the company’s path to a strong earnings recovery remains cautious. CGS International has resumed coverage of AEM with a “Hold” rating, reflecting both optimism about new customer momentum and a wait-and-see approach regarding meaningful, sustained growth.

1H25 Performance: Revenue Rises, Profit Rebounds, but Headwinds Remain

In 1H25, AEM reported a revenue of S\$190.3 million, a 9.6% year-on-year (YoY) increase, and a remarkable 283.9% YoY surge in net profit to S\$3.2 million. The growth was mainly attributed to the successful deployment of the AMPS-BI solution and a pull-in of orders from its key customer. However, a S\$5.9 million foreign exchange loss and a S\$4.1 million inventory provision led to a slight loss of S\$0.3 million in 2Q25. Book value per share as of June 2025 stood at S\$1.52.

Segment 1H25 Revenue (S\$ million) YoY Change (%) % of Total Revenue
Test Cell Solutions 118.6 +18.8% 62%
Contract Manufacturing 67.0 -4.7% 35%
Instrumentation (not specified) N/A 2.4%

Outlook: Flat 2H25 Guidance, Improving Prospects for FY26-27

For 2H25, AEM has guided revenue in the range of S\$170 million to S\$190 million, pointing to a flat or slightly declining half-on-half (HoH) trend. The second half will see continued AMPS-BI product shipments, but some orders were pulled forward into the first half, potentially dampening sequential growth. Management expects a ramp-up in production for a major AI/HPC customer in late FY25/early FY26 and is optimistic about a memory customer evaluating final test handler solutions, which could transition to volume production by late FY26.

Valuation and Recommendation: Hold As Investors Await New Customer Contributions

CGS International has upgraded AEM to a “Hold” rating, with a new target price of S\$1.44, up from S\$1.27. The valuation is based on 12.1x FY27F P/E, reflecting expectations of an earnings recovery and potential surge in demand from new products. AEM’s share price as of the report date was S\$1.41, with a modest 2.1% upside to the target price.

Rating Current Price (S\$) Target Price (S\$) Up/Downside (%) Market Cap (S\$ million) Consensus (Buy/Hold/Sell)
Hold 1.41 1.44 2.1% 444.1 Buy 1 / Hold 0 / Sell 2

Shareholder Structure and Price Performance

– Venezio Investments: 12.4% – EPF: 7.8% – Pandanus Associates: 4.9%
AEM’s share price has been volatile, with a 1-month performance of -8.5%, a 3-month gain of 16.5%, and a 12-month gain of 16.5%. Relative to the SIMSCI, AEM underperformed by -21% over the past year.

Financial Summary: Recent Results and Three-Year Forecasts

Metric 2023A 2024A 2025F 2026F 2027F
Revenue (S\$ m) 481.3 380.4 370.0 430.4 458.5
Net Profit (S\$ m) (1.3) 11.6 18.0 32.5 37.4
Core EPS (S\$) 0.02 0.04 0.06 0.10 0.12
Core EPS Growth (%) -94.7 71.2 54.7 81.2 14.8
FD Core P/E (x) 65.30 37.74 24.53 13.54 11.79
DPS (S\$) 0.014 0.026 0.030
Dividend Yield (%) 0.00 0.00 1.02 1.83 2.11
Net Gearing (%) 5.2 10.3 -19.7 -16.4 -18.0
ROE (%) 1.41 2.44 3.65 6.36 6.95

Company Overview: Global Reach and Segment Breakdown

AEM provides advanced semiconductor and electronics test solutions, with a global footprint that includes manufacturing in Singapore, Malaysia, Indonesia, Vietnam, Finland, South Korea, and the US.

  • Test Cell Solutions: 62.4% of 1H25 revenue, generating 92.7% of 1H25 pretax profit, with a 4.3% pretax profit margin.
  • Contract Manufacturing: 35.2% of 1H25 revenue, 16.4% of 1H25 pretax profit, 1.34% pretax profit margin.
  • Instrumentation: 2.4% of 1H25 revenue, posted a S\$0.5 million pretax loss.

Industry Overview: Semiconductor and Contract Manufacturing Trends

The Semiconductor Industry Association reported global semiconductor sales of US\$179.7 billion in 2Q25, an increase of 7.8% quarter-on-quarter and 19.6% year-on-year for June 2025. The World Semiconductor Trade Statistics projects global sales to reach US\$728 billion in 2025 and US\$800 billion in 2026, supporting a bullish long-term outlook for the sector.
The global electronic manufacturing services (EMS) market was US$609.8 billion in 2024 and is projected to reach US$1,033.2 billion by 2032, a CAGR of 6.9%. OEMs are increasingly relying on EMS providers for scalable production and supply chain resilience.

Financials: Recent History, Recovery Timeline, and Forecast Assumptions

AEM’s earnings upcycle began in FY17 and peaked in FY21 with revenue of S\$565.4 million and net profit of S\$92.0 million. FY22 was exceptional, with record revenue and profit as customers pulled forward orders due to Covid-19. The subsequent years saw normalization and a temporary oversupply, leading to a loss in FY23. The company returned to profitability in FY24.
Key forecast assumptions:

  • FY25F revenue: S\$370 million (midpoint of guidance), net profit: S\$18.0 million (no repeat of major FX loss or inventory provision).
  • FY26-27F: Revenue recovery to S\$430.4 million and S\$458.5 million, respectively. Net profit margins expected to improve to 7.5% (FY26F) and 8.1% (FY27F), with net profits of S\$32.3 million and S\$37.4 million.

Risks: Customer Concentration, Technology, and FX Exposure

  • Customer Concentration: The key customer accounted for 49.7% of FY24 revenue. Any order cancellation, delay, or technology shift could impact AEM’s earnings. Notably, the key customer has lost market share recently, increasing this risk.
  • Technology Risk: AEM’s success depends on innovation and customer adoption of new products. Failure to keep pace or differentiate could erode revenue.
  • Foreign Exchange Risk: With revenue and costs in multiple currencies, FX volatility is a notable factor. A S\$5.9 million FX loss in 1H25 significantly reduced operating profit.

Peer Comparison: How AEM Stacks Up

Company Ticker P/E CY25F P/E CY26F 3-Year EPS CAGR (%) P/BV CY25F ROE CY25F (%) Dividend Yield CY25F (%)
AEM Holdings Ltd AEM SP 24.5 13.5 49.6 0.88 3.5 1.0
Advantest Corp 6857 JP 49.1 27.1 30.2 12.94 38.7 0.5
Teradyne Inc TER US 35.3 24.1 18.6 5.86 17.2 0.4

Board and Management: Depth of Industry Expertise

AEM’s board comprises industry veterans from technology, finance, and private equity backgrounds, including:

  • Loke Wai San (Non-Executive Chairman, Novo Tellus Capital Partners CEO)
  • Chok Yean Hung (Non-Executive Director, ex-CEO, co-founder of UTAC and Ellipsiz Test/EEMS Asia)
  • André Andonian (Independent Director, ex-McKinsey Managing Partner, Board of Analog Devices)
  • Chou Yen Ning @ Alice Lin (Independent Director, ex-CFO Oracle Asia Pacific)
  • James Toh Ban Leng (Lead Independent Director, Novo Tellus Capital Partners)
  • Loh Kin Wah (Independent Director, extensive semiconductor leadership experience)
  • Tham Min Yew (Russell) (Non-Executive Director, Temasek International)

ESG & Sustainability: Recent Progress and Ongoing Initiatives

AEM’s LSEG ESG score improved from C- in FY20 to C in FY23, reflecting better management practices, though challenges remain in shareholder, workforce, and emissions categories.
Key highlights:

  • Average employee training hours in 2024: 33.8 (up from 11.0 in 2021)
  • Implementation of a Learning Management System (since June 2021)
  • Environmental compliance: 11 years with no regulatory breaches; water-glycol mixtures from cooling systems are properly recycled

Balance Sheet Highlights: FY23-FY27F

Metric 2023A 2024A 2025F 2026F 2027F
Total Cash & Equivalents (S\$ m) 101.8 43.8 193.8 181.4 194.6
Shareholders’ Equity (S\$ m) 467.5 485.7 499.2 523.4 551.4
Total Liabilities (S\$ m) 234.5 180.9 187.9 197.9 202.5

Conclusion: Cautious Optimism, Steady Execution Required

AEM Holdings Ltd stands at a critical juncture. While its fundamentals are stabilizing and new customer opportunities are emerging, headwinds such as customer concentration and FX volatility remain material. Management has set the stage for a meaningful earnings recovery in FY26-27, but investors will want to see evidence of delivery from new customers before re-rating the stock. CGS International’s “Hold” rating reflects a balanced view: upside potential exists, but patience and prudent monitoring are warranted for the coming quarters.

JD Health International Inc: Technical Buy with Promising Upside Targets

Date of Report: September 25, 2024Broker: CGS International Securities Stock Overview Company Name: JD Health International IncStock Code: 6618Last Price: 26.75 Investment Recommendation JD Health International Inc is identified as a Technical Buy in...

IRPC Q4 2024 Preview: Net Loss Expected, But Long-Term Value Remains – Buy Rating Maintained

Comprehensive Analysis of IRPC by UOB Kay Hian – January 23, 2025 Comprehensive Analysis of IRPC by UOB Kay Hian Date of Report: January 23, 2025 Broker Name: UOB Kay Hian Overview of IRPC...

Financial Analysis Report

Broker: UOB Kay Hian Date of Report: 30 June 2025 Singapore Mid-Cap Stocks Set for Liquidity Surge: Top Picks, Analysis, and Outlook for 2025 MAS’ S\$5 Billion Equity Market Development Program: A Liquidity Game-Changer...